Grant: Discovery Grants Program - Individual
University of Guelph
$24,000.00
Developing markers for predicting bovine embryonic health and viability
FY 2013-14
Summary
Global cost of Early embryonic mortality (EEM) in total cattle population accrues to about $ 1.28 trillion annually. There exists very little information on why some embryos develop and some ""slow down"" and eventually arrest. Introduction of refined biological techniques like metabolomics and gene expression studies at the level of single embryos can provide new insights. Our preliminary studies using metabolomics and gene array technologies on slow and fast growing embryos has revealed distinct differences in their energy pathways. Therefore, we hypothesize that altered embryonic metabolism causes the differences in observed embryonic developmental potential and that metabolomics approach applied to spent media collected from high and low developmental potential embryos will define variations in their metabolism pathways. We propose to 1) Characterize the metabolomic signatures of single, slow and fast growing bovine embryos, 2) Elucidate the molecular mechanism for the differential metabolic profiles between slow and fast cleaving embryos, 3) Validate putative metabolite markers using metabolic inhibitors and enhancers during in vitro culture. The study would involve the use of single embryos for in vitro culture, timed media aspirations for metabolomic assessment using 600 MHz proton NMR, gene expression studies, mitochondrial health assessment, ATP assays, siRNA gene inhibition or use of chemical metabolic inhibitors or enhancers. To our knowledge, this study will be the first of its kind to link energy pathway genes and metabolomic profile of preimplantation mammalian embryos. Information derived from this study is anticipated to provide a better understanding of the preimplantation period of development in mammals and also holds the promise to evolving markers for embryo assessment as a tool to enhancing livestock production. Canadian cattle industry generates over $ 38.6 billion annually and improvement in the efficiency of cattle production system through these tools of reproductive biotechnology will have significant economic benefits to the cattle industry.
Program
Discovery Grants Program - Individual
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
402554-2012
Name nom
Madan, Pavneesh
Department département
Biomedical Sciences
Organization id
24
Institution établissement
University of Guelph
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2013
Competition year année de concours
2012
Award amount
24000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1502
Committee name en
Biological Systems and Functions
Committee name fr
Systèmes et fonctions biologiques
Area of application code
101
Area of application group en
Agriculture and primary food production
Area of application group fr
Agriculture et produits alimentaires primaires
Area of application en
Animal production and animal primary products
Area of application fr
Production animale et produits animaux primaires
Research subject code
5505
Research subject group en
Animal biology
Research subject group fr
Biologie animale
Research subject en
Animal reproduction
Research subject fr
Reproduction animale
Partie
2
Nb partie
5
Application title
Developing markers for predicting bovine embryonic health and viability
Keyword
NSERC
Application summary
Global cost of Early embryonic mortality (EEM) in total cattle population accrues to about $ 1.28 trillion annually. There exists very little information on why some embryos develop and some ""slow down"" and eventually arrest. Introduction of refined biological techniques like metabolomics and gene expression studies at the level of single embryos can provide new insights. Our preliminary studies using metabolomics and gene array technologies on slow and fast growing embryos has revealed distinct differences in their energy pathways. Therefore, we hypothesize that altered embryonic metabolism causes the differences in observed embryonic developmental potential and that metabolomics approach applied to spent media collected from high and low developmental potential embryos will define variations in their metabolism pathways. We propose to 1) Characterize the metabolomic signatures of single, slow and fast growing bovine embryos, 2) Elucidate the molecular mechanism for the differential metabolic profiles between slow and fast cleaving embryos, 3) Validate putative metabolite markers using metabolic inhibitors and enhancers during in vitro culture. The study would involve the use of single embryos for in vitro culture, timed media aspirations for metabolomic assessment using 600 MHz proton NMR, gene expression studies, mitochondrial health assessment, ATP assays, siRNA gene inhibition or use of chemical metabolic inhibitors or enhancers. To our knowledge, this study will be the first of its kind to link energy pathway genes and metabolomic profile of preimplantation mammalian embryos. Information derived from this study is anticipated to provide a better understanding of the preimplantation period of development in mammals and also holds the promise to evolving markers for embryo assessment as a tool to enhancing livestock production. Canadian cattle industry generates over $ 38.6 billion annually and improvement in the efficiency of cattle production system through these tools of reproductive biotechnology will have significant economic benefits to the cattle industry.